AbbVie got FDA approval for antibiotic treatment Emblaveo. Regeneron’s Linvoseltamab BLA was accepted ... Fallon Capital Management pressed Astellas Pharma to cut costs and overhaul drugs research.

The Food and Drug Administration (FDA) has approved Emblaveo™ (aztreonam and avibactam), in combination with metronidazole, for patients 18 years and older who have limited or no alternative ...

The healthcare sector, too, has seen advances with AbbVie's EMBLAVEO™ gaining FDA approval for a combination antibiotic, and the European Medicines Agency recommending its arthritis treatment ...

Amazon has to continue cutting costs if it wants to invest in new growth opportunities. That's according to Amazon's retail CEO, Doug Herrington, who stressed the need to cut costs and invest in ...

"The American people are counting on President Trump to bring down costs and grow the U.S. economy. Tariffs on Canada and Mexico put those goals in serious jeopardy and risk destabilizing the ...

Just how high prices will get – and when – all depend on the extent to which businesses will absorb the higher cost of tariffs or reconfigure their supply chains to minimize costs, as well as ...

FDA recently announced new safety requirements for DPD screening in cancer patients. Kristine Ashcraft, founder and CEO of ...

SINGAPORE: Singaporeans' concerns over the rising cost of living go "far beyond" the Goods and Services Tax (GST), said Prime Minister Lawrence Wong on Monday (Mar 3) as he reiterated the reasons ...

We found that when adding a 16-year-old driver to a parent’s policy, the average car insurance cost jumped from $2,603 per year to $5,011 per year. That’s an average increase of 103%.

Personal finance website WalletHub analyzed the prices of 26 common grocery items in 50 states, then added the costs and compared them with the median household income to determine where people ...

According to HomeAdvisor, a network and marketplace made up of construction professionals, the national average range to build a home in the United States is currently between $138,937 and $531,294.